Nuveen Asset Management, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$144.95 - $152.29 $1.06 Million - $1.12 Million	-7,333 Reduced 3.32%	213,362 $17.7 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $2.01 Million - $3.53 Million	24,177 Added 12.3%	220,695 $18.3 Million
Q1 2022 May 16, 2022	SELL	$110.08 - $142.92 $323,745 - $420,327	-2,941 Reduced 1.47%	196,518 $23 Million
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $2.15 Million - $3.21 Million	-21,597 Reduced 9.77%	199,459 $21 Million
Q3 2021 Nov 12, 2021	SELL	$98.85 - $138.91 $836,271 - $1.18 Million	-8,460 Reduced 3.69%	221,056 $29.8 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $355,672 - $567,843	5,407 Added 2.41%	229,516 $22.3 Million
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $9.44 Million - $13.5 Million	-147,324 Reduced 39.66%	224,109 $15.3 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $6.23 Million - $9.41 Million	95,799 Added 34.76%	371,433 $31.8 Million
Q3 2020 Nov 16, 2020	SELL	$59.04 - $77.95 $1.51 Million - $1.99 Million	-25,496 Reduced 8.47%	275,634 $17.9 Million
Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $3.39 Million - $8.68 Million	116,876 Added 63.43%	301,130 $22 Million
Q1 2020 May 14, 2020	SELL	$27.51 - $57.29 $7.72 Million - $16.1 Million	-280,553 Reduced 60.36%	184,254 $6.27 Million
Q4 2019 Feb 14, 2020	SELL	$40.86 - $57.65 $16.4 Million - $23.2 Million	-402,265 Reduced 46.39%	464,807 $25.3 Million
Q3 2019 Nov 14, 2019	SELL	$37.38 - $49.47 $708,463 - $937,604	-18,953 Reduced 2.14%	867,072 $36.2 Million
Q2 2019 Aug 15, 2019	BUY	$39.79 - $67.01 $35.3 Million - $59.4 Million	886,025 New	886,025 $38.8 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account